Featured Biotech ETFs Rally as Global Blood Therapeutics Surges on Potential Pfizer Deal By Max ChenAugust 5, 2022
Featured Biotech ETFs Advance on Speculation of a Takeover Bid for Global Blood Therapeutics By Max ChenAugust 4, 2022
Featured Intuit’s Strong Quarterly Results, Forward Guidance Lift Software Tech ETFs By Max ChenMay 25, 2022
Leveraged & Inverse Channel Up Over 50%, This Inverse Tech ETF Continues to Shine By Ben HernandezMay 10, 2022
Thematic Investing Channel Innovation Should Help Fuel Growth in This China Biotech ETF By Ben HernandezApril 11, 2022
Disruptive Technology Channel Disruptive Tech ETFs Rally on Encouraging Dialogue Between Russia and Ukraine By Max ChenMarch 29, 2022
Disruptive Technology Channel Demographic Trends Bode Well for Fintech ETF By Tom LydonMarch 23, 2022
Beyond Basic Beta Channel Vaccine Stocks Lift Biotech ETFs as China Enters Lockdowns By Max ChenMarch 14, 2022
